Connor, Clark & Lunn Investment Management (CC&L)’s LifeMD LFMD Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio LFMD Stock Details LFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-925,685	Closed	-$12.6M	–	1619
2025 Q2	$12.6M	Sell	925,685 -56,209	-6%	-$531K	0.04%	342
2025 Q1	$5.34M	Buy	981,894 +50,600	+5%	+$287K	0.02%	483
2024 Q4	$4.61M	Buy	931,294 +165,378	+22%	+$867K	0.02%	503
2024 Q3	$4.01M	Buy	765,916 +48,201	+7%	+$278K	0.02%	494
2024 Q2	$4.92M	Buy	717,715 +121,808	+20%	+$1.11M	0.02%	428
2024 Q1	$6.13M	Buy	595,907 +444,266	+293%	+$3.28M	0.03%	390
2023 Q4	$1.26M	Buy	151,641 +59,264	+64%	+$426K	0.01%	794
2023 Q3	$577K	Buy	+92,377	New	+$400K	﹤0.01%	978

Other funds holding LFMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s LFMD Position: Q3 2025 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of LifeMD (LFMD) in Q3 2025, closing a stake of 925,685 shares — an estimated $12.6M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in LFMD in Q3 2023 and held it in 8 quarters. The position peaked at $12.6M in Q2 2025. 114 funds tracked by Wall St. Rank hold LFMD as of Q3 2025.

Connor, Clark & Lunn Investment Management (CC&L) reported no remaining LifeMD position as of Q3 2025 after selling out during the quarter.
Connor, Clark & Lunn Investment Management (CC&L) sold 925,685 LifeMD shares in Q3 2025, an estimated $12.6M.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in LifeMD in Q3 2023 and held it in 8 quarters.
Connor, Clark & Lunn Investment Management (CC&L)'s LifeMD position peaked at $12.6M in Q2 2025.
114 funds tracked by Wall St. Rank held LifeMD as of Q3 2025.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2025, filed 13 Nov 2025.